All over the news today is the anti-Ebola drug ZMAPP (which hasn t even been proven to work), and the difficulties in making large quantities of it. ACSH s Dr. Bloom comments, The good news is that since 52 percent of the people in the US think GM foods are unsafe, Mapp Biopharmaceutical, the maker of the drug should really only need to make half as much. Why is this? Let s take a look at how ZMAPP is made.
In an opinion piece published in today s Wall Street Journal, Dr. Henry I. Miller, Robert Wesson Fellow in Scientific Philosophy and Public Policy at Stanford s Hoover Institution and former ACSH trustee, discusses the significant benefit that biopharming can provide for the development of medicines if only regulators can become more tolerant.